Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Drug Dev Res ; 84(8): 1595-1623, 2023 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-37751330

RESUMEN

Selective cyclooxygenase (COX)-2 inhibitors have several advantages over nonselective COX inhibitors (nonsteroidal anti-inflammatory drugs [NSAIDs]), including the absence of adverse effects (renal and hepatic disorders) associated with the long-term use of standard NSAIDs, as well as an improved gastrointestinal profile. The pyridazine nucleus is regarded as a promising scaffold for the development of powerful COX-2 inhibitors, particularly when selectively functionalized. This article summarizes some methods for the synthesis of pyridazine derivatives. Furthermore, it covers all of the pyridazine derivatives that have appeared as selective COX-2 inhibitors, making it useful as a reference for the rational design of novel selective COX-2 inhibitors.


Asunto(s)
Antiinflamatorios no Esteroideos , Inhibidores de la Ciclooxigenasa 2 , Inhibidores de la Ciclooxigenasa 2/efectos adversos , Ciclooxigenasa 2 , Antiinflamatorios no Esteroideos/efectos adversos , Tracto Gastrointestinal , Riñón
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA